Market Overview

US Stock Futures Edge Higher Ahead Of Fed Minutes, Alcoa Earnings

US Stock Futures Edge Higher Ahead Of Fed Minutes, Alcoa Earnings
Related VC
Earnings Scheduled For February 22, 2018
5 Biggest Price Target Changes For Thursday
Visteon's (VC) CEO Sachin Lawande on Q4 2017 Results - Earnings Call Transcript (Seeking Alpha)
Related DYAX
Here Are The Most Notable Insider Transactions Hitting The Market
Stocks Hitting 52-Week Highs

Pre-open movers

US stock futures traded slightly higher in early pre-market trade. The Federal Open Market Committee will issue minutes of its latest meeting at 2:00 p.m. ET. Alcoa Inc. (NYSE: AA) is projected to post its Q1 earnings after the closing bell. Futures for the Dow Jones Industrial Average gained 10.50 points to 17,795.50, while the Standard & Poor's 500 index futures surged 1.40 points to 2,069.15. Futures for the Nasdaq 100 index rose 1.20 points to 4,335.20.

A Peek Into Global Markets

European markets were mostly lower today, with the Spanish Ibex Index falling 0.46%, STOXX Europe 600 Index surging 0.18% and German DAX 30 index falling 0.49%. French CAC 40 Index slipped 0.15% and London's FTSE 100 Index rose 0.54%.

In Asian markets, Japan's Nikkei Stock Average rose 0.76%, China's Shanghai Composite Index jumped 0.84%, Hong Kong's Hang Seng Index climbed 3.80% and India's BSE Sensex gained 0.67%.

Broker Recommendation
Analysts at Barclays upgraded Visteon Corporation (NYSE: VC) from Equal-weight to Overweight and raises the price target from $107.00 to $121.00.

Visteon shares fell 0.25% to close at $98.16 yesterday.

Breaking news

  • Dyax Corp. (NASDAQ: DYAX) today announced the pricing of an underwritten public offering of 7,400,000 shares of its common stock, offered at a price to the public of $27.00 per share. To read the full news, click here.
  • The Boards of Shell (NYSE: RDS-A)(NYSE: RDS-B) and BG (OTC: BRGYY) are pleased to announce that they have reached agreement on the terms of a recommended cash and share offer to be made by Shell for the entire issued and to be issued share capital of BG. To read the full news, click here.
  • Gilead Sciences, Inc. (NASDAQ: GILD) announced that it has submitted a New Drug Application to the U.S. Food and Drug Administration for two doses of an investigational fixed-dose combination of emtricitabine and tenofovir alafenamide (200/10 mg and 200/25 mg) (F/TAF) for the treatment of HIV-1 infection in adults and pediatric patients age 12 years and older, in combination with other HIV antiretroviral agents. To read the full news, click here.
  • CareTrust REIT, Inc. (NASDAQ: CTRE) today announced that it has acquired Mira Vista Care Center, a 94-bed skilled nursing facility located in Mount Vernon, Washington, for $9.1 million. To read the full news, click here.

Posted-In: Barclays US Stock FuturesNews Eurozone Futures Global Pre-Market Outlook Markets


Related Articles (AA + BRGYY)

View Comments and Join the Discussion!